OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study.
Can J Neurol Sci
; 49(4): 540-552, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-34218836
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Botulinum Toxins, Type A
/
Migraine Disorders
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Can J Neurol Sci
Year:
2022
Document type:
Article
Affiliation country:
Canada
Country of publication:
United kingdom